{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:21:06Z","timestamp":1791048066752,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":5150,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1006\/mthe.2002.0669","type":"journal-article","created":{"date-parts":[[2002,9,25]],"date-time":"2002-09-25T18:55:31Z","timestamp":1032980131000},"page":"342-348","source":"Crossref","is-referenced-by-count":54,"title":["Impact of Preimmunization on Adenoviral Vector Expression and Toxicity in a Subcutaneous Mouse Cancer Model"],"prefix":"10.1016","volume":"6","author":[{"given":"Maria T.","family":"Vlachaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Hernandez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Chhikara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin S.","family":"The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Brian","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Barrera-Saldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estuardo","family":"Aguilar-Cordova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/mthe.2002.0669_bib1","unstructured":"Horwitz, M. S.1996. Adenoviruses. In Fields VirologyB. Fields, D. M. Knipe, and P. M. Howley, Eds., pp. 2149\u20132171. Lippincott, Philadelphia."},{"key":"10.1006\/mthe.2002.0669_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0169-409X(93)90059-D","article-title":"Adenoviral vectors for gene transfer","volume":"12","author":"Trapnell","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1006\/mthe.2002.0669_bib3","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.gt.3301611","article-title":"Complement activation by recombinant adenoviruses","volume":"8","author":"Cichon","year":"2001","journal-title":"Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/10430349950018229","article-title":"In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial","volume":"10","author":"Herman","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0360-3016(01)01698-4","article-title":"Enhanced therapeutic effect of multiple injections of HSV-TK+GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model","volume":"51","author":"Vlachaki","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1006\/mthe.2002.0669_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0360-3016(01)01692-3","article-title":"Phase I-II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer\u2014a preliminary report","volume":"51","author":"Teh","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1006\/mthe.2002.0669_bib8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/104303401753204535","article-title":"Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer therapy failing radiotherapy","volume":"12","author":"Miles","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/hum.1997.8.10-1275","article-title":"Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors","volume":"8","author":"Morral","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.gt.3300508","article-title":"Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination","volume":"4","author":"Bramson","year":"1997","journal-title":"Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/10430340152712692","article-title":"Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons","volume":"13","author":"Morral","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib12","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1089\/hum.1998.9.14-2121","article-title":"Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma","volume":"9","author":"Molnar-Kimber","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib13","first-page":"1","article-title":"In situ gene therapy for prostate cancer","volume":"11","author":"Thompson","year":"1999","journal-title":"Oncol. Res."},{"key":"10.1006\/mthe.2002.0669_bib14","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0022-5347(05)67534-9","article-title":"Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer","volume":"163","author":"Shalev","year":"2000","journal-title":"J. Urol."},{"key":"10.1006\/mthe.2002.0669_bib15","first-page":"412","article-title":"Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver","volume":"3","author":"Yang","year":"1996","journal-title":"Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib16","first-page":"467","article-title":"Two rat models of hepatic fibrosis. a morphologic and molecular comparison","volume":"63","author":"Sun","year":"1990","journal-title":"Lab. Invest."},{"key":"10.1006\/mthe.2002.0669_bib17","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1128\/JVI.65.11.6242-6251.1991","article-title":"Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus","volume":"65","author":"Clabough","year":"1991","journal-title":"J. Virol."},{"key":"10.1006\/mthe.2002.0669_bib18","first-page":"49","article-title":"The occurrence of circulating immune complexes and viral antigens in idiopathic thrombocytopenic purpura","volume":"28","author":"Lurhuma","year":"1977","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/mthe.2002.0669_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/10430340152712629","volume":"13","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib20","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","article-title":"Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons","volume":"96","author":"Morral","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/mthe.2002.0669_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/10430349950018904","article-title":"Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy","volume":"10","author":"Lanuti","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/hum.1995.6.8-1039","article-title":"Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression","volume":"6","author":"Fang","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2002.0669_bib23","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/1521-4141(200007)30:7<2101::AID-IMMU2101>3.0.CO;2-P","article-title":"The effect of TGF-\u03b21 on immune responses of naive versus memory CD4+ Th1\/Th2 T cells","volume":"30","author":"Ludviksson","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/mthe.2002.0669_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001602906696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001602906696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T13:14:35Z","timestamp":1583586875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001602906696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S1525001602906696"],"URL":"https:\/\/doi.org\/10.1006\/mthe.2002.0669","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}